Participant consumed grapefruit or grapefruit products and solutions within 3 days ahead of the primary dose of study drug. - "Our study exposed the very important part of the KLF16/MYC regulatory axis in modulating tumor expansion and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, like OTX015 or ABBV-744, https://archerykvgr.shoutmyblog.com/31395319/rumored-buzz-on-abbv-744-for-small-cell-lung-cancer-research